Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Stock Quote Today & Recent News Conatus Pharmaceuticals CNAT

Healthcare Biotechnology
Conatus Pharmaceuticals Inc is a biotechnology company focused on the development and commercialization of novel medicines to treat chronic diseases with significant unmet need. The company is developing emricasan, an orally active pan-caspase inhibitor, for the treatment of patients with chronic liver disease. Emricasan is designed to reduce the activities of human caspases, which are enzymes... see more
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >

Current News (NDAQ:CNAT)

Histogen Reports Second Quarter 2021 Earnings and Provides Business Update

GlobeNewswire August 11, 2021

Histogen to Present at the Canaccord Genuity 41st Annual Growth Conference

GlobeNewswire July 29, 2021

Histogen to Report Second Quarter 2021 Financial Results on August 11, 2021

GlobeNewswire July 28, 2021

Histogen Announces Initiation of HST 003 Phase 1/2 Trial for Knee Cartilage Regeneration

GlobeNewswire June 30, 2021

Histogen and Amerimmune Announce Positive Top-Line Study Results from its Phase 1 Study of Emricasan in Mild Symptomatic COVID-19 Patients

GlobeNewswire June 22, 2021

Histogen Announces Closing of $6.5 Million Registered Direct Offering Priced At-the-Market under Nasdaq Rules

GlobeNewswire June 9, 2021

Histogen Announces $6.5 Million Registered Direct Offering Priced At-the-Market under Nasdaq Rules

GlobeNewswire June 7, 2021

Histogen Provides Update on its Development Programs and Pipeline Focus

GlobeNewswire June 3, 2021

Histogen and Amerimmune Report Publication on Emricasan in COVID-19

GlobeNewswire May 19, 2021
View More News ››

Opinion & Analysis (NDAQ:CNAT)

Minimizing mistakes in a volatile biotech market

The Life Sciences Report February 25, 2016
View More Opinion ››

Bullboard Posts (NDAQ:CNAT)

HSTO ..... Thanks for the dough Joe

Cheers to scalping   Money for nothing !
Iseneschal - March 17, 2023

HSTO ....in some here at sub $1.29

C what happens
Iseneschal - March 17, 2023

HSTO ..... U have to ask yourself....

How on earth does this trade 10 x's it's shares o/s and only be up 45 f'king cents  I smell a rat !!!!!!!!!!!!!!!!!!!!!...
Iseneschal - March 17, 2023

HSTO..... I call this "No Mans Land"

I'm fairly certain of the direction....keeping that to myself for this moment.... $1.31  Cheers !
Iseneschal - March 17, 2023

HSTO ..... just remember that this still isn't Strike 3 ; )

The last bastion of support hasn't been breached yet  Might still have legs
Iseneschal - March 17, 2023

HSTO...... Lol.... I rest my case

U know now !
Iseneschal - March 17, 2023
View more Bullboard ››

Lithium Ionic Corp

Lithium Ionic Corp

Lithium Ionic Corp. is a Canadian mining company. The Company is engaged exploring and developing its lithium properties in ...
View More »